ARTICLE | Regulation
Medimmune
March 27, 1995 8:00 AM UTC
DASHED: Great expectations based on a prospective pipeline - and strong analyst support - evaporated when an advisory panel turned back MedImmune's RespiGam polyclonal antibody for respiratory syncy...